Home Biosimilar Antibodies Metabolism PCSK9 antibody Tafolecimab (Anti-PCSK9) For research use only.
Not for use in humans.

Tafolecimab (Anti-PCSK9)

Synonyms: IBI-306

Tafolecimab (Anti-PCSK9) is a human lgG2 monoclonal antibody that specifically targets PCSK-9. It may be used in studies of hypercholesterolaemia. MW :145.34 KD.

Tafolecimab (Anti-PCSK9)

Purity & Quality Control

Choose Selective PCSK9 Inhibitors

Expand to Check More
1. "+" indicates inhibitory effect. Increased inhibition is marked by a higher "+" designation. 2. "✔" indicates inhibitory effect, but without specific value.

Biological Activity

Description Tafolecimab (Anti-PCSK9) is a human lgG2 monoclonal antibody that specifically targets PCSK-9. It may be used in studies of hypercholesterolaemia. MW :145.34 KD.

Product Details

CAS No. 2225109-03-3
Isotype Human IgG2SA
Source CHO
Formulation 100mMPro-Ac,20mMArg-Ac，pH5.0
Storage
(From the date of receipt)		 Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.

Comparison of Clones for

*Literature analysis of various clone (for this target) products available on the market shows that Selleck's selected clones are more frequently applied. (data until September 2024)

Tech Support

If you have any other enquiries, please leave a message.

* Indicates a Required Field

Please enter your name.
Please enter your email. Please enter a valid email address.
Please write something to us.
Tags: buy Tafolecimab (Anti-PCSK9) | Tafolecimab (Anti-PCSK9) supplier | purchase Tafolecimab (Anti-PCSK9) | Tafolecimab (Anti-PCSK9) cost | Tafolecimab (Anti-PCSK9) manufacturer | order Tafolecimab (Anti-PCSK9) | Tafolecimab (Anti-PCSK9) distributor